That, coupled with a cash situation that must be near critical would seem to suggest this company is on its last legs. There are a few un-partnered molecules they are still working on, I believe, but I really wonder what the next 6 months look like for Addex.
That said, the PPS didn't suffer too much (yet?) with this bad news. And at this rate, any GOOD news (i.e. encouraging clinical studies and/or partnerships) could turn the share price around in a hurry.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.